PMID

Data

Article Title

Organization

Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.

Pfizer

Organic anion transporter 3 interacts selectively with lipophilicß-lactam antibiotics.

Wilkes University

Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.

Nippon Boehringer Ingelheim

Characterization of methotrexate transport and its drug interactions with human organic anion transporters.

Kyorin University

Interaction of human organic anion transporters with various cephalosporin antibiotics.

Kyorin University

Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters.

Kyorin University

Interactions of human organic anion as well as cation transporters with indoxyl sulfate.

Nagoya University School Of Medicine

Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux.

Georg-August-Universit£T

Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).

Kyoto University Hospital

Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.

Kyorin University

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

Novartis Pharma

Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain.

Bristol-Myers Squibb

Discovery of (

Bristol-Myers Squibb

Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.

Hemoshear Therapeutics

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

TBA

Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting.

Pfizer

Pharmacological urate-lowering approaches in chronic kidney disease.

West China Hospital Of Sichuan University

Dihydrophenanthrenes from Juncus effusus as Inhibitors of OAT1 and OAT3.

Tianjin University

Characterization of ochratoxin A transport by human organic anion transporters.

Kyorin University

Characterization of uremic toxin transport by organic anion transporters in the kidney.

University Of Tokyo